131
Views
5
CrossRef citations to date
0
Altmetric
Review

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

, , &
Pages 581-591 | Published online: 06 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pratima Chowdary, Emma Fosbury, Anne Riddell & Mary Mathias. (2016) Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A. Journal of Blood Medicine 7, pages 187-198.
Read now
M Rosa Hernández, Patricia Urbán, Elisenda Casals, Joan Estelrich, Ginés Escolar & Ana M Galán. (2012) Liposomes bearing fibrinogen could potentially interfere with platelet interaction and procoagulant activity. International Journal of Nanomedicine 7, pages 2339-2347.
Read now

Articles from other publishers (3)

Alicia Fernandez-Fernandez, Romila Manchanda & Manisha Kumari. (2023) Lipid-engineered nanotherapeutics for cancer management. Frontiers in Pharmacology 14.
Crossref
A. M. Shibeko, A. N. Balandina & M. A. Panteleev. (2020) New approaches to the diagnosis and treatment of coagulation disorders. Pediatric Hematology/Oncology and Immunopathology 19:4, pages 243-250.
Crossref
Anuj Mittal, Naveen Kumar & Nar Singh Chauhan. (2019) Curcumin Encapsulated PEGylated Nanoliposomes: A Potential Anti-Infective Therapeutic Agent. Indian Journal of Microbiology 59:3, pages 336-343.
Crossref